Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vesicular Tubular Clusters01:45

Vesicular Tubular Clusters

3.1K
After budding out from the ER membrane, some COPII vesicles lose their coat and fuse with one another to form larger vesicles and interconnected tubules called vesicular tubular clusters or VTCs. These clusters constitute a compartment at the ER-Golgi interface known as ERGIC (Endoplasmic Reticulum Golgi Intermediate Compartment). The ERGIC is a mobile membrane-bound cargo transport system that sorts proteins secreted from ER and delivers them to the Golgi.
With the help of motor proteins such...
3.1K
Vesicular Trasport: Endocytosis, Transcytosis and Exocytosis01:18

Vesicular Trasport: Endocytosis, Transcytosis and Exocytosis

3.1K
Vesicular transport is a cellular process that encompasses the engulfment of particles or dissolved substances by cells. It involves endocytosis, transcytosis, and exocytosis.
Endocytosis is a cellular mechanism that involves the inward folding of the cell membrane to create vesicles that capture and transport large drug molecules. This process comprises two distinct methods: pinocytosis (often referred to as "cell drinking") and phagocytosis (often referred to as "cell...
3.1K
What are Viruses?00:50

What are Viruses?

127.9K
Overview
127.9K
Mechanisms of Drug Absorption: Paracellular, Transcellular, and Vesicular Transport01:23

Mechanisms of Drug Absorption: Paracellular, Transcellular, and Vesicular Transport

1.7K
Drugs need to permeate cell membranes to reach their target sites after administration. Orally administered drugs must transcend intestinal epithelial membrane barriers to infiltrate the systemic circulation. Drugs with a molecular weight of less than 500 Daltons diffuse through gaps between neighboring cells, called paracellular pathways.
However, most drugs use the transcellular route, traversing directly through the cell membranes via two mechanisms: passive and active transport. Passive...
1.7K
Scalar and Vectors01:22

Scalar and Vectors

2.1K
In mechanics, commonly used terms like force, speed, velocity, and work can be classified as either scalar or vector quantities. A scalar is a physical quantity that can be described by its magnitude alone and does not require any directional components. Examples of scalar quantities are mass, area, and length.
Scalar quantities with the same physical units can be added or subtracted according to the usual algebra rules for numbers. For example, a class ending 10 min earlier than 50 min lasts...
2.1K
Acceleration Vectors01:30

Acceleration Vectors

21.8K
In everyday conversation, accelerating means speeding up. Acceleration is a vector in the same direction as the change in velocity, Δv, therefore the greater the acceleration, the greater the change in velocity over a given time. Since velocity is a vector, it can change in magnitude, direction, or both. Thus acceleration is a change in speed or direction, or both. For example, if a runner traveling at 10 km/h due east slows to a stop, reverses direction, and continues their run at 10 km/h...
21.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editorial Expression of Concern: A FADD-dependent innate immune mechanism in mammalian cells.

Nature·2026
Same author

Primate resident memory T cells activate humoral and stromal immunity.

Immunity·2025
Same author

Antigen-presenting cell activation requires intrinsic and extrinsic STING signaling after the phagocytosis of DNA-damaged cells.

Science immunology·2024
Same author

Exogenous non-coding dsDNA-dependent trans-activation of phagocytes augments anti-tumor immunity.

Cell reports. Medicine·2024
Same author

Innate Immune System Regulated by Stimulator of Interferon Genes, a Cytosolic DNA Sensor, Regulates Endothelial Function.

Journal of the American Heart Association·2023
Same author

Evaluation of the immunogenicity and efficacy of an rVSV vaccine against Zika virus infection in macaca nemestrina.

Frontiers in virology (Lausanne, Switzerland)·2023

Related Experiment Video

Updated: Jan 25, 2026

Growth, Purification, and Titration of Oncolytic Herpes Simplex Virus
06:14

Growth, Purification, and Titration of Oncolytic Herpes Simplex Virus

Published on: May 13, 2021

7.4K

Vesicular stomatitis virus as an oncolytic vector.

Glen N Barber1

  • 1Department of Microbiology and Immunology, Sylvester Comprehensive Cancer Center, University of Miami School of Medicine, Miami, Florida 33136, USA. gbarber@med.miami.edu

Viral Immunology
|January 27, 2005
PubMed
Summary

Vesicular stomatitis virus (VSV), a non-pathogenic RNA virus, shows promise for cancer therapy by selectively replicating in malignant cells. Engineered VSV could enhance tumor susceptibility to chemotherapy and boost immune responses against cancer.

More Related Videos

Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats
08:55

Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats

Published on: April 15, 2016

9.9K
Ex Vivo Infection of Live Tissue with Oncolytic Viruses
12:08

Ex Vivo Infection of Live Tissue with Oncolytic Viruses

Published on: June 25, 2011

13.2K

Related Experiment Videos

Last Updated: Jan 25, 2026

Growth, Purification, and Titration of Oncolytic Herpes Simplex Virus
06:14

Growth, Purification, and Titration of Oncolytic Herpes Simplex Virus

Published on: May 13, 2021

7.4K
Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats
08:55

Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats

Published on: April 15, 2016

9.9K
Ex Vivo Infection of Live Tissue with Oncolytic Viruses
12:08

Ex Vivo Infection of Live Tissue with Oncolytic Viruses

Published on: June 25, 2011

13.2K

Area of Science:

  • Virology
  • Oncology
  • Immunology

Background:

  • Malignant cells exhibit impaired host defense mechanisms, particularly involving the interferon system, which normally prevents viral replication.
  • Vesicular stomatitis virus (VSV), a negative-stranded RNA virus, demonstrates preferential replication in these compromised malignant cells compared to normal cells.

Purpose of the Study:

  • To explore the potential of VSV as an oncolytic virus for cancer therapy.
  • To investigate the feasibility of genetically engineering VSV for enhanced anti-cancer effects, including increased tumor cell targeting and sensitization to other treatments.

Main Methods:

  • Utilizing VSV, a well-characterized and genetically tractable RNA virus.
  • Leveraging the inherent property of VSV to replicate preferentially in cancer cells with defective antiviral responses.
  • Exploring the generation of VSV recombinants for therapeutic applications.

Main Results:

  • VSV demonstrates selective replication in malignant cells, suggesting oncolytic potential.
  • VSV's genetic simplicity and known interactions with the immune system make it an attractive candidate for modification.
  • Engineered VSV holds the potential to increase tumor susceptibility to chemotherapy and augment host anti-tumor immune responses.

Conclusions:

  • VSV and other RNA viruses represent a promising avenue for novel cancer therapies.
  • The oncolytic and gene-targeting capabilities of VSV can be exploited to develop innovative cancer treatments.
  • Further development of VSV-based therapies could lead to improved treatment strategies for various cancers.